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Background: Patients’ positive illness perceptions (IPs) significantly contribute to treatment success. The Brief
Illness Perception Questionnaire (Brief IPQ) is widely used in various diseases for assessing IPs. It was developed
in English-speaking countries and studies on it in Arab countries are scarce.
Objectives, Setting and design: This observational cross-sectional study aimed to cross-culturally adapt the
Brief IPQ English version into a modern Arabic language version and determine its psychometric properties
in a sample of Lebanese cardiac disease patients. This study was approved by the Institutional Review Board
of Saint Joseph University of Beirut, Lebanon.
Participants: A convenience sample of 30 patients with cardiac disease were recruited during routine visits to
cardiologists’ offices in Beirut, Lebanon. Inclusion criteria were at least one cardiac disease for at least 6 months
with no acute episode or exacerbation of the disease during the 6 preceding months, age]18 years, and the
ability to read and comprehend Arabic. The pre-final version of the Brief IPQ Arabic version was tested for face
and content validity. The meaning, comprehensibility, and acceptability were studied by individual interviews.
For discriminant validity and internal consistency of the Brief IPQ Arabic version (Brief IPQ-Ar), 100 patients
were recruited in a similar manner using the same inclusion criteria. To assess reproducibility, 30 patients,
selected randomly from the 100 patients, filled the questionnaire a second time, 34 weeks after its first ad-
ministration and under the same conditions.
Main outcome measures: Psychometric properties of the Brief IPQ-Ar among Lebanese patients suffering
from cardiac diseases.
Results: Semantic equivalence between the Brief IPQ-Ar questions and patients’ descriptions was 100%.
Cronbach’s alpha was 0.717, which shows good internal consistency. Reproducibility was satisfactory (ICC
values0.776). Moreover, the Brief IPQ-Ar discriminated participants according to the type of cardiac disease
and treatment-related characteristics.
Conclusions: We confirm that the Brief IPQ-Ar is appropriate for exploring IPs in cardiac disease patientswhose first
language is Arabic. Further research should be conducted to test this Arabic version in other types of diseases.
Keywords: adaptation; Arabic; Brief IPQ; cardiology; cross-cultural; psychometric
Responsible Editor: Hani Benamer, University of Birmingham, United Kingdom.
*Correspondence to: Lydia Rabbaa Khabbaz, Laboratoire de Pharmacologie, Pharmacie Clinique
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H
eart diseases are a leading cause of mortality
worldwide and a frequent cause of hospital admis-
sions, including in Lebanon (1, 2). The prevalence of
coronary artery disease was estimated at 20% in Lebanon (3).
Patients’ beliefs about their diseases are one of the factors
predicting the decision to seek care (4). Illness perceptions
(IPs) are the patients’ thoughts about the symptoms they
experience, and are among the psychosocial factors that
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could explain the variance in physical functioning among
patients (5).
IP belongs to the core concepts in the Commonsense
Model of Self-Regulation (CSM) developed by Leventhal
et al. (6). It addresses how individuals respond emotion-
ally and cognitively (illness representations) to a specific
internal or external stimulus, such as a symptom or sign
of illness, and how these cognitions and emotions guide
coping responses (7). According to the CSM, there are
five dimensions of cognitive representations of illness:
identity (individual’s label for the symptom), consequences
(individual’s beliefs about the consequences of illness),
timeline (individual’s beliefs about the duration of illness),
control (individual’s beliefs about whether the illness can
be treated or kept under personal control), and cause
(individual’s beliefs about the cause of the illness) (6). CSM
also postulates that these cognitions have a causal effect on
individuals’ coping efforts in the face of a health threat,
such as a chronic condition (8). Coping behavior is defined
as efforts to manage a stressful situation by changing
cognitions or behavior (9). Coping styles used by patients
could include problem-focused coping, emotion-focused
coping, avoidant coping, and socially supported coping
(10). Avoidant coping has been strongly associated with
adverse emotional outcomes, such as anxiety, depression,
and negative affectivity (1113). Coping and IPs are
associated: negative IPs are linked to increased psycholo-
gical distress and maladaptive coping (14). Interventions
to align CSM with medical knowledge and to provide
patients with the adaptive understanding required to
manage their own health are increasingly prevalent (15).
Cardiovascular diseases (CVD) are the main cause of
death and activity limitations worldwide, and several studies
have shown that the manifestation and clinical evolution
of CVD are related to psychosocial factors such as anger,
hostility, perceived stress, anxiety, and depression (16). The
American guidelines for cardiac rehabilitation (17) as well as
European (18) and Australian guidelines (19) suggest that
rehabilitation programs should therefore be focused on
psychosocial issues to improve patients’ well-being and
achieve a better quality of life. For patients with congestive
heart failure, affect is considered an essential aspect of
emotional well-being (20).
An important factor in the adjustment to chronic
conditions is the patient’s illness perception (21). Negative
IPs are reportedly associated with more complications
after CVD (22), and various studies have indicated that
perceptions of less negative illness consequences are as-
sociated with better clinical outcomes (23). Negative IPs in
post-myocardial infarction are associated with fatigue;
fatigued patients tend to expect longer illness duration,
have more negative emotional beliefs, and perceive more
serious consequences (7). Illness perception is also an
important aspect in the management of hypertension
besides pharmacological interventions (24).
In patientswith congestive heart failure, changing patients’
IPs has been shown to improve (1) recovery following myo-
cardial infarction (25), (2) hypertension management (24),
and (3) emotional distress (anxiety and depression) (26).
Given all the reasons above, examining patients’ IPs in
chronic diseases and specifically in cardiac diseases is of
paramount importance.
The assessment of IPs has evolved from interviews to
validated questionnaires (27). One of the questionnaires,
developed in 1996, is the Illness Perception Questionnaire
(IPQ), which has over 80 items (28). The Brief IPQ, de-
veloped and validated in 2006 (29), has been widely used
for assessing IPs in various diseases (30, 31) and among
adults and adolescents (32). It has the advantages of being
brief and easy to understand.
The IPQ and the Brief IPQ were developed in English-
speaking countries and have been translated and vali-
dated in different cultures. To assess IPs across cultures, it
is generally recommended to adapt questionnaires to the
target language and culture (29, 33, 34). To the best of
our knowledge, no validation of the Brief IPQ has been
done in Arab countries so far, where the cultural context
is different. One study published an adapted Arabic
version of the full-length IPQ, but it concluded that the
factor structure did not concur with prior findings on the
IPQ (35). Another translated the Brief-IPQ to Arabic and
used it, but the authors did not validate their version (36).
The aim of this study was to cross-culturally adapt the
nine-item Brief IPQ English version into the Brief IPQ
Arabic version (Brief IPQ-Ar) (Modern Standard Arabic)
and determine its face validity, content validity, reprodu-
cibility, and concurrent validity in a sample of Lebanese
patients suffering from cardiac diseases.
Methods
Ethical considerations
The study was approved by the Institutional Review
Board of Saint Joseph University of Beirut, Lebanon
(ref. Usj-2014-1). All participants provided their written
informed consent to participate in this study.
Perception of illness measure: the Brief IPQ
The Brief IPQ is a nine-item questionnaire designed to
assess each dimension of illness perception. Five items
assess cognitive illness representations: consequences
(item 1), timeline (item 2), personal control (item 3), treat-
ment control (item 4), and identity (item 5). Two items
assess emotional representations: concern (item 6) and
emotions (item 8). Finally, one item assesses illness com-
prehensibility (item 7). Responses are scored on a scale
ranging from 0 to 10. For items 1, 2, 5, 6, and 8, a 0
score indicates a good disease perception, and a score of
10 indicates a bad disease perception. For items 3, 4, and 7,
a score of 0 indicates a bad disease perception, and 10
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indicates a good disease perception. Assessment of the
causal representation is by an open-ended response item,
which asks patients to list the three most important causal
factors in their illness (item 9) (29).
Transcultural adaptation
The Brief IPQ (29) was cross-culturally adapted using the
guidelines of Beaton et al. (33). First, two bilingual
translators whose mother tongue is Arabic produced two
independent translations from English to Arabic. The
two translators and the research leader synthesized the
results of the two translations and reached a consensus
on a common translation. Then, two translators whose
mother tongue is English and blinded to the original
English version translated the Arabic version back into
English. The first author of the Brief IPQ (29) was
contacted for approval of the backward translation. A
committee consisting of experts in questionnaire valida-
tion, an Arabic linguist, and all the translators reached
a consensus on semantic equivalence. This equivalence
means that the word of the target language has the same
meaning as the corresponding word of the source
language and also reflects the same nuance. This means
that the corresponding words in the original English
version and the Arabic version have the same meaning.
This committee contacted the first author of the Brief
IPQ (29) for approval of the backward translation.
Step 1: face and content validity
Face and content validity of the pre-final version of the
Brief IPQ-Ar A were tested on a convenience sample of
30 Lebanese patients (Fig. 1). Patients had at least one
cardiac disease for at least 6 months but no acute episode
or exacerbation of the disease during the 6 preceding
months, were aged ] 18 years, and could read and com-
prehend Arabic. The meaning, comprehensibility, and
acceptability were studied in individual interviews with
the participants about what they thought was meant by
each question.
Step 2: discriminant validity and internal consistency
One hundred Lebanese patients were recruited using
the same inclusion criteria as in step 1. Discriminant
validity and internal consistency of the Brief IPQ-Ar were
assessed.
Step 3: reproducibility
To assess reproducibility, 30 patients selected randomly
from the 100 participants in step 2 filled the question-
naire a second time in the same conditions 2 weeks after
the first administration.
Study population
In this observational cross-sectional study, patients were
recruited during their routine visits to cardiologists
between 15 January and 15 March 2015 (convenience
sampling). Criteria for inclusion were: Lebanese patients
diagnosed with at least one cardiac disease for at least
6 months with no acute episode or exacerbation of the
disease during the 6 preceding months, aged 18 years or
older. Participants had to be able to read and compre-
hend Arabic language.
All eligible patients were recruited in person and
invited to enroll after providing their written consent.
Step 1 interviews were conducted by a trained research
assistant. For steps 2 and 3, participants completed a
self-administered questionnaire consisting of basic socio-
demographic profile, clinical information, and the Brief
IPQ-Ar (Fig. 1). Questionnaires were completed in the
cardiology clinic. The socio-demographic characteristics
of the participants included their age, gender, marital
status, and level of education.
Clinical information about the participants included
the type of cardiac disease according to the WHO clas-
sification (37) and treatment-related characteristics, such
as the number of drugs taken by the patient, the number of
drug intakes per day, the number of drug pills per day, and
treatment duration. The presence or absence of concomi-
tant non-cardiac disease(s) was also recorded.
Fig. 1. Procedure and stages of the assessment of the validity and reproducibility of the Arabic version of the Brief Illness
Perception Questionnaire.
Brief Illness Perception Questionnaire Arabic version
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Statistical analysis
Statistical analysis was performed using SPSS for windows
version 17.0 (USA). The alpha error was set at 0.05.
For a cross-cultural adaptation of the original Brief
IPQ into Brief IPQ-Ar, the percentage of agreement on
semantic equivalence in patients for face and content
validity was calculated. Internal consistency, reproduci-
bility, and discriminant properties were evaluated.
As the scores of the Brief IPQ-Ar and continuous
variables (numbers of pills/day, and treatment duration)
were not normally distributed (Kolmogorof Smirnov test).
The Kruskal-Wallis test, Mann Whitney test, and Spearman
correlation coefficient were used.
To assess the degree of internal consistency, scores of
items 3, 4, and 7 were reversed and Cronbach’s alpha
coefficients were calculated; Spearman correlation coeffi-
cients were used to measure the item-score correlations.
The acceptable level for the overall scale was set at 0.80
for Cronbach’s alpha.
Reproducibility is a component of precision in a meas-
urement system. It is the ability of a questionnaire to con-
sistently reproduce the same measurement under the same
conditions. It was assessed by repeating the administration
of the Brief IPQ-Ar to 30 subjects among the 100 who filled
the questionnaire the first time, 2 weeks after the first
administration. Intra-class correlation coefficients (ICC)
with 95% confidence interval were calculated. ICC values
] 0.7 were considered acceptable.
Discriminant validity was evaluated by measuring
the degree to which the scores of the different items of
the Brief IPQ-Ar and clinical data were related. It was
supposed that the Brief IPQ-Ar can discriminate between
participants according to their clinical data as repre-
sented by the type of cardiac disease, treatment duration,
number of pills per day, concomitant diseases, number
of drugs taken, number of drug intakes, and number of
pills per day. The Kruskal-Wallis test, Mann Whitney
test, and Spearman correlation coefficient were used for
this purpose.
Considering that it is widely recognized that chronicity
and the difficulty of living with severe chronic conditions
tax the individual’s psychological and emotional resources
(11), it was hypothesized that patients having factors
adding to their disease management burden would have
poorer IPs for some dimensions, such as treatment or
timeline dimensions. Contributing factors include con-
comitant disease(s), a large number of drugs and pills taken
daily, a large number of drug intakes per day, and long
treatment duration.
The relationships between sociodemographic variables
and the different items of the Brief IPQ-Ar were also
studied by the Kruskal-Wallis test, Mann Whitney test,
and Spearman correlation coefficient.
Results
Step 1: face and content validity (n30)
Thirty patients (51% male) participated; 64% were B65
years old, 65% were married, and 79% had a secondary
or better level of schooling.
Testing of the pre-final version of the Brief IPQ-Ar showed
a 100% semantic equivalence between the Brief IPQ-Ar
questions and patients’ descriptions. All the patients stated
that they understood the questions and gave semantic
equivalences.
Step 2: assessment of internal consistency (n100)
A total of 100 patients (53% male) were included in the
study; 62% were B65 years old, 69% were married, and
81% had a secondary or better level of schooling. The
major socio-demographic and disease/drug related char-
acteristics of the participants are presented in Table 1.
Twenty-five percent of the participants had hyperten-
sion, 10% heart failure, 8% cardiac arrhythmias, 4%
cardiomyopathies, and 32% presented more than one
cardiac disease at the time of questionnaire completion.
The average treatment duration of cardiac disease(s) was
8.595.4 years.
Table 2 summarizes the answers of participants to the
questions of the Brief IPQ-Ar. Cronbach’s alpha was
0.717 and varied from 0.649 to 0.743 when item 1 or 3
was deleted, respectively. Item scale correlations varied
from 0.373 (item 3) to 0.727 (item 8) (Table 3). The score
of each Brief IPQ-Ar item was significantly correlated
with the total Brief IPQ-Ar score (pB0.05) (Table 4).
Assessment of discriminant validity (n100)
Participants suffering from concomitant non-cardiac dis-
eases scored significantly higher in the following dimen-
sions: timeline, personal control, and coherence. They
thought that their illness would continue for a longer
period of time: average scores were 6.7393.12 when no
non-cardiac disease was associated, and 8.9991.73 when
non-cardiac diseases were associated (pB0.0001). They
also felt that they understood their illness (average scores
were 5.7792.96 versus 7.0195.56; p0.003) and have
control over it (average scores were 3.2392.96 versus
5.3192.78; p0.005), when compared to participants
with no concomitant non-cardiac diseases.
Moreover, for the timeline dimension, significant dif-
ferences were also observed: those who felt that their illness
would last longer had more than one cardiac disease
(average score 9.0691.70), while participants with cardiac
arrhythmias felt that their illness would be shorter (average
score 7.0092.33; p 0.05). Furthermore, concern and emo-
tional response were significantly higher among partici-
pants suffering from cardiomyopathies (average scores
6.5093.11 and 7.0092.94; p0.05 and 0.03, respectively)
(Table 5).
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The number of drug intakes per day was significantly
associated with the identity dimension: participants with
three or more drug intakes per day reported more symptoms
of their illness than those with fewer daily drug intakes:
average scores 2.7292.54 with one drug intake/day,
3.7892.39 with two, and 4.7792.45 with three or more
(p 0.02). However, the number of drugs taken by the
patients was not significantly associated with any dimen-
sion of the Brief IPQ-Ar (p0.05).
Participants with longer treatment duration were
less concerned about their cardiac disease (pB0.0001,
r 0.35) and thought their cardiac disease would con-
tinue for a longer time (p0.002, r0.31), (Table 6).
Participants taking more drug pills per day felt that
their illness affected their lives more (p0.03, r0.21)
and that they experienced more symptoms compared to
those who took fewer pills (p0.009, r0.277) (Table 6).
Relationship between Brief IPQ-Ar version scores
and sociodemographic variables (n100)
When comparing item scores between males and females,
the identity dimension showed a significant difference
between sexes (p 0.049), with higher scores among males
(4.092.5) than among females (3.092.5). Men experi-
enced more symptoms from their cardiac disease com-
pared to women.
The timeline and coherence dimensions were signifi-
cantly related to marital status (p0.006 and 0.02,
respectively). Single participants thought that their ill-
ness would continue for a shorter time (average score:
6.9092.90) than other participants, and divorced partici-
pants felt they understood their illness to be worse than
that of other participants (average score 2.7594.85).
The age of the participants was significantly related to
the timeline, concern, and emotional response. Elderly
participants (65 years) thought that their illness would
continue longer than younger participants (average score:
9.2391.83; pB0.0001). However, they were less con-
cerned about their illness (average score: 3.0692.94;
p0.02) and less affected emotionally than younger
participants (average score: 3.0492.87), (p0.03).
Participants with higher levels of education were more
concerned about their illness than participants with lower
levels of education (p0.04, r0.21) (Table 6).
Step 3: assessment of reproducibility
Thirty subjects (52% male) participated; 61% were B65
years old, 68% were married, and 77% had a secondary
or better level of schooling. Reproducibility was satisfac-
tory, with ICC values 0.776 (Table 3).
Discussion
Patients’ evaluations of their health care are now an estab-
lished component of quality assessment (38). In chronic
diseases, the current literature points to the value of as-
sessing illness representations in understanding and pre-
dicting mental and physical outcomes (39). Therefore, a
reliable and simple tool to evaluate IPs in various diseases
is needed in Arab countries, and specifically in cardiac
Table 1. Socio-demographic and disease/drug related char-


















University degree 36 (36.0)
Missing data 2 (2.0)
Type of cardiac disease
Hypertension 25 (25.0)
Heart failure 10 (10.0)
Cardiac arrhythmias 8 (8.0)
Cardiomyopathies 4 (4.0)
Ischemic heart disease or coronary
artery disease
21 (21.0)
More than one disease 32 (32.0)
Presence of concomitant non-cardiac diseases
No 22 (22.0)
Yes 78 (78.0)
Number of drugs taken by the patienta
1 50 (50.0)
2 38 (38.0)
] 3 12 (12.0)
Number of drug intakes per daya
1 36 (36.0)
2 51 (51.0)
] 3 13 (13.0)




] 4 11 (11.0)
Duration of treatment (months)a 8.595.4
aOnly drugs used to treat cardiac diseases are considered in
this table.
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diseases because cardiometabolic diseases are the leading
cause of mortality in the Middle East and North Africa,
accounting for nearly one million deaths annually (40, 41).
The adaptation of a questionnaire for use in another
country and another language is time consuming and
costly. However, to date, it is the best way to get an
equivalent metric for any self-attribute being considered
(33). The cross-cultural adaptation of a health-status self-
administered questionnaire for use in a new country,
culture, and/or language necessitates the use of a unique
method to reach equivalence between the original source
and target versions of the questionnaires (33).
This study was the first to translate to Arabic and
validate a widely used tool, the Brief IPQ, and perform a
cross-cultural adaptation on a group of Lebanese patients.
The study was conducted according to the methodology
adopted by the International Society of Quality of Life
Assessment (IQOLA) (42, 43). The process described in
this paper was a process of translating to Arabic and
adapting the Brief IPQ to make it relevant and valid in a
new culture. Translation does not automatically provide a
valid measure of another culture’s health, and this was
carefully verified throughout the process and the testing
described in this paper.
The Brief IPQ-Ar showed good psychometric proper-
ties among Lebanese patients suffering from cardiac
diseases. There was a 100% semantic equivalence between
the Brief IPQ-Ar questions and patients’ descriptions.
Cronbach’s alpha was 0.717, which indicates good in-
ternal consistency, and it was 0.649 and 0.743 when,
respectively, item 1 or 3 was deleted. Reproducibility was
satisfactory, with ICC values above 0.776. Moreover,
different items of the Brief IPQ-Ar were able to dis-
criminate between patients according to the type of
Table 2. Percent distribution of the participants’ answers to each item of the Arabic version of the Brief Illness Perception
Questionnaire
Consequences (How much does your illness affect your life?)
No affect at all 0 1 2 3 4 5 6 7 8 9 10 Severely affects
25% 10% 10% 10% 4% 10% 5% 15% 7% 1% 3%
Timeline (How long do you think your illness will continue?)
A very short time 0 1 2 3 4 5 6 7 8 9 10 Forever
25% 0% 1% 3% 3% 6% 6% 5% 8% 9% 58%
Personal control (How much control do you feel you have over your illness?)
Absolutely no control 0 1 2 3 4 5 6 7 8 9 10 Extreme control
14% 2% 7% 13% 2% 20% 6% 16% 11% 4% 5%
Treatment control (How much do you think your treatment can help your illness?)
Not at all 0 1 2 3 4 5 6 7 8 9 10 Extremely helpful
0% 0% 3% 2% 4% 14% 8% 21% 22% 10% 16%
Identity (How much do you experience symptoms from your illness?)
No symptoms at all 0 1 2 3 4 5 6 7 8 9 10 Many severe
17% 5% 16% 17% 9% 13% 6% 9% 7% 1% 0%
Concern (How concerned are you about your illness?)
Not at all concerned 0 1 2 3 4 5 6 7 8 9 10 Extremely concerned
20% 6% 12% 8% 8% 17% 5% 12% 6% 3% 3%
Understanding (How well do you feel you understand your illness?)
Don’t understand 0 1 2 3 4 5 6 7 8 9 10 Very clearly
3% 2% 6% 2% 3% 16% 4% 20% 19% 4% 21%
Emotional response (How much does your illness affect you emotionally: Makes you angry, scared, upset or depressed?)
Not affected 0 1 2 3 4 5 6 7 8 9 10 Extremely affected
23% 5% 9% 10% 9% 12% 8% 15% 6% 0% 3%
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cardiac disease, concomitant non-cardiac diseases, and
treatment-related characteristics.
The timeline dimension scores were worse among
patients above 65 years, patients with concomitant non-
cardiac diseases, widowed patients, and those with a longer
duration of treatment. This means that these patients feel
that their illness would be present for a very long time. For
the personal control dimension, the scores were better
among patients suffering from concomitant non-cardiac
diseases compared to those who had no non-cardiac
diseases. For the coherence dimension, scores were worse
in patients with concomitant non-cardiac diseases and
better among single patients. For the identity dimension,
males scored higher than females, and patients with a
greater number of daily drug intakes showed higher scores.
Mohammed et al. (36), using the Brief-IPQ in patients
suffering from tuberculosis (TB) in Sudan, previously
showed that patients who experienced more symptoms
(identity) expected severe consequences and had poor
personal control over their illness, but that study did not
examine differences between males and females nor did it
explore drug intakes among patients. For the concern
dimension, bad scores were found among patients above
65 years and patients suffering from ischemic heart disease
or coronary artery disease. However, concern was better
among participants with higher levels of education and
those taking a high number of drug pills per day, which
could mean that they perceived their illness as less
threatening. We could not find published studies to help
Table 3. Internal consistency and reproducibility of the Arabic version of the Brief Illness Perception Questionnaire
Internal consistency
Cronbach’s Alpha No. of items
0.717 8
Item-total statistics
Scale mean if item
deleted




Cronbach’s alpha if item
deleted
Consequence 25.64 116.576 0.574 0.649
Timeline 27.69 138.681 0.370 0.697
Personal control 24.05 144.573 0.153 0.743
Treatment control 26.39 141.614 0.377 0.697
Identity 25.67 128.728 0.504 0.670
Concern 25.30 119.444 0.560 0.653
Understanding 24.26 137.225 0.220 0.734
Emotional response 25.40 118.323 0.588 0.647
Reproducibility
95% confidence interval
Intra-class correlation Lower bound Upper bound p
Consequence 0.981 0.960 0.991 B0.0001
Timeline 0.952 0.902 0.977 B0.0001
Personal control 0.955 0.907 0.979 B0.0001
Treatment control 0.776 0.580 0.887 B0.0001
Identity 0.938 0.874 0.970 B0.0001
Concern 0.964 0.926 0.983 B0.0001
Understanding 0.939 0.875 0.970 B0.0001
Emotional response 0.966 0.930 0.984 B0.0001
Table 4. Spearman’s correlations between the Arabic version
of the Brief Illness Perception Questionnaire (Brief IPQ-Ar)
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explain all our results because no previous studies assessed
all the factors examined in our present work. We think that
our observations justify future investigations with larger
sample size and different clinical conditions; examining
patients’ satisfaction with treatment together with illness
perception could also help understand what was observed
in our study regarding the relation between some di-
mensions of the Brief IPQ-Ar and patients’ treatment
characteristics.
Finally, for the emotional response dimension, lower
scores were observed among patients above 65 years; these
patients, with poor emotional representations, would be
expected to have a poor quality of life, as reported in a
previous study done in Sudan using the Brief-IPQ (36).
Three dimensions of the Brief-IPQ (identity, emotional
impact, and concern) have been associated with anxiety
or depression in previous studies (44), whose authors
proposed that IPs may be a useful basis for determining
the need for psychological interventions in some patients.
Our results encourage such interventions in patients with
cardiac diseases, based on their Brief-IPQ domain scores.
Study limitations
This study was conducted on a convenience sample,
which means that the representativeness of the sample
could be an issue. Moreover, the study relied on a self-
reported questionnaire and thus there is a risk of
reporting and social desirability bias. The respondents
may have forgotten pertinent details or over- or under-
estimated them to avoid revealing private information.
The participants were assured that the results were
confidential, so external pressures were unlikely to have
significantly affected the responses. Finally, associations
between IPs and coping behavior may be bi-directional,
but the cross-sectional nature of this study did not allow










































































































































































































































































































































































































































































































































































































































































































Table 6. Spearman correlations between the Brief IPQ-Ar
dimensions and level of education, treatment duration, and










Consequence 0.040 0.063 0.200*
Timeline 0.058 0.307** 0.048
Personal control 0.005 0.068 0.032
Treatment control 0.034 0.106 0.007
Identity 0.085 0.053 0.262**
Concern 0.209* 0.347** 0.074
Understanding 0.053 0.060 0.084
Emotional response 0.112 0.246* 0.098
Spearman correlation; *pB0.05; **pB0.01; $missing values.
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Conclusions
The results indicate that the Brief IPQ-Ar version is an
appropriate instrument to explore illness perception in
native Arabic-speaking patients suffering from cardiac
diseases. Further research should be conducted to test this
Arabic version in other types of diseases. The results also
shed light on factors, not examined before, that could
affect illness perception items in such patients, in parti-
cular, the number of drug pills taken daily by the patient
and the number of drug intakes.
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